Arora A, Sarin S K
1 Department of Radiology, Institute of Liver and Biliary Sciences, New Delhi, India.
2 Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Br J Radiol. 2015 Aug;88(1052):20150008. doi: 10.1259/bjr.20150008. Epub 2015 May 29.
Portal vein thrombosis (PVT) is a frequent complication of liver cirrhosis, but it can also occur as a primary vascular disorder amid absent liver disease. Extrahepatic portal vein obstruction (EHPVO) refers to the obstruction of the extrahepatic portal vein with or without involvement of the intrahepatic portal vein branches, splenic and/or superior mesenteric vein. It is a distinct disorder that excludes PVT occurring in concurrence with liver cirrhosis or hepatocellular carcinoma. The term "EHPVO" implies chronicity and is principally reserved for a long-standing condition characterized by cavernous transformation of the portal vein. The most characteristic imaging manifestation is the formation of portoportal collaterals (via the venous plexi of Petren and Saint) that allow hepatopetal flow. However, this collateral circulation is insufficient resulting in clinically significant pre-hepatic portal hypertension, wherein the liver function and structure remain preserved until late. Although the long-term (more than 10 years) survival with controlled variceal bleeding is up to 100%, affected individuals have an impaired quality of life owing to portal cavernoma cholangiopathy, hypersplenism, neurocognitive dysfunction and growth retardation. Imaging diagnosis is not always straightforward as the collaterals can also present as a tumour-like solid mass that can be inadvertently biopsied. Moreover, EHPVO has its implications for the biliary tree, arterial circulation, liver/splenic volumes and stiffness, which merit proper understanding but have not been so well described in literature. In this review, we present the complete spectrum of the vascular, biliary and visceral changes with a particular emphasis on what our medical/surgical hepatology colleagues need to know from us in the pre-operative and post-operative settings.
门静脉血栓形成(PVT)是肝硬化的常见并发症,但也可作为无肝脏疾病情况下的原发性血管疾病发生。肝外门静脉阻塞(EHPVO)是指肝外门静脉阻塞,伴或不伴有肝内门静脉分支、脾静脉和/或肠系膜上静脉受累。它是一种独特的疾病,不包括与肝硬化或肝细胞癌同时发生的PVT。术语“EHPVO”意味着慢性,主要用于描述以门静脉海绵样变性为特征的长期病症。最具特征性的影像学表现是形成门静脉旁侧支循环(通过Petren和Saint静脉丛),允许血流向肝。然而,这种侧支循环不足,导致临床上显著的肝前门静脉高压,其中肝功能和结构在晚期之前保持完好。尽管控制静脉曲张出血后的长期(超过10年)生存率高达100%,但由于门静脉海绵状血管瘤胆管病、脾功能亢进、神经认知功能障碍和生长发育迟缓,患者的生活质量受损。影像学诊断并不总是一目了然,因为侧支循环也可表现为肿瘤样实性肿块,可能会被无意中进行活检。此外,EHPVO对胆管树、动脉循环、肝脏/脾脏体积和硬度有影响,值得正确认识,但在文献中对此描述并不充分。在本综述中,我们介绍了血管、胆管和内脏变化的全貌,特别强调了我们的医学/外科肝病学同事在术前和术后需要从我们这里了解的内容。